Cargando…
Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4(+) T Cells of Patients with Relapsing-Remitting Multiple Sclerosis
MicroRNAs (miRNAs) are a family of noncoding RNAs that play critical roles in the posttranscriptional regulation of gene expression. Accumulating evidence supports their involvement in the pathogenesis of multiple sclerosis (MS). Here, we compare miR-17 expressions in CD4(+) T cells from relapsing-r...
Autores principales: | Meira, Maria, Sievers, Claudia, Hoffmann, Francine, Rasenack, Maria, Kuhle, Jens, Derfuss, Tobias, Kappos, Ludwig, Lindberg, Raija L. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036714/ https://www.ncbi.nlm.nih.gov/pubmed/24901013 http://dx.doi.org/10.1155/2014/897249 |
Ejemplares similares
-
Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development
por: Meira, Maria, et al.
Publicado: (2016) -
PARP-1 deregulation in multiple sclerosis
por: Meira, Maria, et al.
Publicado: (2019) -
Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy
por: Rust, Heiko, et al.
Publicado: (2016) -
Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis
por: Lorscheider, Johannes, et al.
Publicado: (2020) -
Natalizumab in cerebrospinal fluid and breastmilk of patients with
multiple sclerosis
por: Callegari, Ilaria, et al.
Publicado: (2023)